Home NDC 50845-0264-1 Snore Defense
Product NDC 50845-0264
Requested package NDC 50845-0264-1
11-digit product format 508450264
Labeler code 50845
Product ID 50845-0264_f235e5ed-43be-4517-bb8e-5f062932c5c3
Type HUMAN OTC DRUG
Nonproprietary name Antimonium tartaricum, Carbo vegetabilis, Grindelia (Robusta), Lung suis, Mucosa nasalis suis, Nux vomica, Sambucus nigra, Sticta pulmonaria, Teucrium marum
Dosage form SPRAY
Route ORAL
Labeler Liddell Laboratories
Marketing category UNAPPROVED HOMEOPATHIC
Marketing start 2020-03-10
Marketing end 2024-12-17
Substance ACTIVATED CHARCOAL; ANTIMONY POTASSIUM TARTRATE; GRINDELIA HIRSUTULA FLOWERING TOP; LOBARIA PULMONARIA; SAMBUCUS NIGRA FLOWERING TOP; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA LUNG; SUS SCROFA NASAL MUCOSA; TEUCRIUM MARUM
Active strength 12 [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmacologic classes Allergens [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Seed Storage Proteins [CS]
NDC exclude flag No
Listing certified through 0000-00-00
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 11 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Code, Status table Captured / source date Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 D Discontinued by firm f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 D Discontinued by firm 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 D Discontinued by firm a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 D Discontinued by firm cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 D Discontinued by firm cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 D Discontinued by firm 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 D Discontinued by firm ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 D Discontinued by firm 0efc9e666f02…f202fb6c5f17…2022-04-09 23:13 UTC · source 2022-04-08 I Inactivated by FDA 86f5da6cb304…a595104c45d7…2022-04-04 05:40 UTC · source 2022-04-01 I Inactivated by FDA bd6a592717d7…303034d00443…
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.
FDA-Initiated Inactive NDC Indexing# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 50845-0264-1 50845026401 30 mL in 1 BOTTLE, SPRAY (50845-0264-1) 30 ml 2020-03-10 2024-12-17 No No Current